Statistics

Total Visits

Views
Cohort compassionate-use program and early access program with cabazitaxel plus prednisone in patients with metastatic castration-resistant prostate cancer (mCRPC) previously treated with docetaxel: analysis by age group63

Select a period of time:

Number of views in the range

Views
Cohort compassionate-use program and early access program with cabazitaxel plus prednisone in patients with metastatic castration-resistant prostate cancer (mCRPC) previously treated with docetaxel: analysis by age group32

Views

Views
May 20250
June 202510
July 20254
August 20250
September 202516
October 20250
November 20252
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States17
Hong Kong10
Brazil2
Costa Rica1
Ireland1
Mexico1
 

Top cities views

Views
Dallas15
Hong Kong10
Austin1
Brejinho1
Catanduva1
Dublin1
Puebla City1
San José1